1. Home
  2. SY vs ALLO Comparison

SY vs ALLO Comparison

Compare SY & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo So-Young International Inc. American Depository Shares

SY

So-Young International Inc. American Depository Shares

HOLD

Current Price

$2.91

Market Cap

289.0M

Sector

Technology

ML Signal

HOLD

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$1.42

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SY
ALLO
Founded
2013
2017
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
289.0M
252.9M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
SY
ALLO
Price
$2.91
$1.42
Analyst Decision
Strong Buy
Buy
Analyst Count
1
11
Target Price
$5.50
$8.67
AVG Volume (30 Days)
786.7K
2.4M
Earning Date
11-17-2025
11-06-2025
Dividend Yield
0.94%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$201,132,009.00
N/A
Revenue This Year
$5.27
N/A
Revenue Next Year
$51.30
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.67
$0.86
52 Week High
$6.28
$3.78

Technical Indicators

Market Signals
Indicator
SY
ALLO
Relative Strength Index (RSI) 42.74 52.49
Support Level $2.78 $1.38
Resistance Level $3.00 $1.57
Average True Range (ATR) 0.17 0.10
MACD -0.01 -0.01
Stochastic Oscillator 23.64 47.17

Price Performance

Historical Comparison
SY
ALLO

About SY So-Young International Inc. American Depository Shares

So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenue from information services fees and reservation services fees from medical aesthetic service providers.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: